Tom Burt

Tom Burt

Director/Board Member at Synthace Ltd.

45 year
Finance
Consumer Services
Health Technology

Profile

Thomas Henry Burt is currently a Director at Synthace Ltd., a Partner at Sofinnova Partners SAS, and a Member of the Association of Engineering Doctorates.
He previously worked as an Investment Director at Ares Life Sciences LP, an Investment Director at Novo Holdings Ltd., an Associate at Piper Sandler Ltd., and an Associate at Novo Principal Investments.
He also served as a Non-Executive Director at Redx Pharma Plc from 2020 to 2023 and as an Assistant Director at Peel Hunt LLP from 2015 to 2017.
Burt holds a graduate degree from the University of Birmingham and undergraduate and doctorate degrees from University College London.

Tom Burt active positions

CompaniesPositionStart
Private Equity Investor 2017-05-31
Director/Board Member 2021-11-11
Association of Engineering Doctorates Corporate Officer/Principal -
All active positions of Tom Burt

Former positions of Tom Burt

CompaniesPositionEnd
REDX PHARMA PLC Director/Board Member 2023-08-31
Analyst-Equity 2017-04-27
Private Equity Analyst 2013-01-30
Chief Investment Officer -
Chief Investment Officer -
See the detail of Tom Burt's experience

Training of Tom Burt

University College London Doctorate Degree
University of Birmingham Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Tom Burt's experience

Connections

83

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
REDX PHARMA PLC

Health Technology

Private companies8

Finance

Finance

Finance

Finance

Finance

Finance

Technology Services

Association of Engineering Doctorates

See company connections
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW